| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -0.01% | +0.03% | -0.04% | -0.04% | — |
| 14d | 1 | +0.00% | -8.06% | +3.50% | -11.55% | -11.55% | — |
| 30d | 1 | +0.00% | -20.98% | +4.98% | -25.95% | -25.95% | — |
| 60d | 1 | +0.00% | -31.15% | +8.50% | -39.65% | -39.65% | — |
| 90d | 1 | +0.00% | -42.53% | +11.96% | -54.49% | -54.49% | — |
| 180d | 1 | +0.00% | -68.74% | +17.38% | -86.11% | -86.11% | — |
| 1y | 1 | +0.00% | -66.09% | +33.51% | -99.60% | -99.60% | — |
| 2y | 1 | +0.00% | -54.60% | +53.33% | -107.93% | -107.93% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,800,000 | — | — | 4,800,000 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,800,000 | — | — | 4,800,000 | Aug 26, 2025 | Aug 28, 2025 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,700 | — | — | 35,700 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 434,000 | — | — | 434,000 | Feb 21, 2024 | Feb 23, 2024 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASE Executive Chairman | 11,000 | $0.89 | $9.8K | 219,001 | Nov 29, 2023 | Nov 30, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 525,000 | — | — | 525,000 | Mar 14, 2023 | Mar 16, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | SALE Executive Chairman | 208,600 | — | — | 0 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASE Executive Chairman | 9,968 | — | — | 9,968 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 525,000 | — | — | 525,000 | Sep 13, 2022 | Sep 15, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | SALE Executive Chairman | 2,500,127 | — | — | 547,698 | May 20, 2022 | May 23, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASE Executive Chairman | 207,001 | — | — | 208,001 | May 20, 2022 | May 23, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,000 | — | — | 7,000 | Mar 16, 2022 | Mar 18, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Nov 17, 2021 | Nov 19, 2021 ↗ | View → |